Ocugen OCGN
NASDAQ OCGN
$0.80 -0.01 (-1.16%)
As of: Oct 21, 2026 · 3:55 PM EDT

Ocugen (OCGN) Capital Leases (2018 - 2019)

Updated

Ocugen's Capital Leases came in at $17,339 for Q3 2019.

Analysis

Ocugen (OCGN) Capital Leases (2018 - 2019) Analysis & Trends

At the end of FY2018, Ocugen's Capital Leases was $33,720.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Ocugen 271.69 Mn 88.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 17,339.00
Dec 31, 2018 33,720.00
API Access

Ocugen Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=OCGN&period=max&api_key=YOUR_API_KEY